Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Cancer Causes Control. 2013 Feb 19;24(5):1005–1014. doi: 10.1007/s10552-013-0175-3

Table 3.

Risk of Barrett's esophagus and daily intake of folate (151 cases and 777 controls)

Food groups Tertile 1 Tertile 2 Tertile 3 P valuec

Folate from foods (μg)
    Median (Range) 92.2 (<109) 125 (109-141) 168 (141-542)
    case/control 59/259 49/259 43/259
    ORa (95% CI) 1.00 0.81(0.53-1.24) 0.67 (0.43-1.05) 0.08
    ORb (95% CI) 1.00 0.85(0.51-1.41) 0.58 (0.33-1.00) 0.05
Fortified folic acid (μg)
    Median (Range) 37.3 (<48.6) 58.9 (48.6-70.7) 94.3 (70.7-588)
    case/control 62/259 50/259 39/259
    ORa (95% CI) 1.00 0.81 (0.53-1.24) 0.66 (0.42-1.03) 0.07
    ORb (95% CI) 1.00 0.75 (0.45-1.24) 0.74 (0.43-1.28) 0.25
Folate acid supplement (μg)
    Dose 0 < 400 ≥ 400
    case/control 69/383 12/77 70/317
    ORa (95% CI) 1.00 0.97 (0.50-1.90) 1.24 (0.85-1.80) 0.27
    ORb (95% CI) 1.00 1.21 (0.56-2.59) 1.19 (0.76-1.88) 0.45
Total folate (μg)
    Median (Range) 179 (< 209) 230 (209-260) 316 (260-1123)
    case/control 67/259 45/259 39/259
    ORa (95% CI) 1.00 0.68 (0.44-1.04) 0.57 (0.36-0.88) 0.01
    ORb (95% CI) 1.00 0.59 (0.36-1.01) 0.52 (0.30-0.67) 0.02
a

OR was adjusted for age and energy intake.

b

OR was adjusted for age, energy intake, sex, ethnicity, smoking status, alcohol consumption, waist to hip ratio (tertile), ever or never use of aspirin, ever or never use of proton pump inhibitor, frequency of the GER symptoms, and physical activity (low, moderate, and high according to metabolic equivalent of task).

c

P value for trend across tertiles.